Literature DB >> 25576719

Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach.

Arian Sultan1, Jakob Lüker2, Boris Hoffmann3, Helge Servatius3, Ali Aydin3, Jana Nührich3, Özge Akbulak3, Doreen Schreiber3, Benjamin Schäffer3, Thomas Rostock4, Stephan Willems3, Daniel Steven2.   

Abstract

BACKGROUND: Catheter ablation (CA) of ventricular tachycardia (VT) is an important treatment option in patients with structural heart disease (SHD) and implantable cardioverter defibrillator (ICD). A subset of patients requires epicardial CA for VT.
OBJECTIVE: The purpose of the study was to assess the significance of epicardial CA in these patients after a systematic sequential endocardial approach.
METHODS: Between January 2009 and October 2012 CA for VT was analyzed. A sequential CA approach guided by earliest ventricular activation, pacemap, entrainment and stimulus to QRS-interval analysis was used. Acute CA success was assessed by programmed ventricular stimulation. ICD interrogation and 24h-Holter ECG were used to evaluate long-term success.
RESULTS: One hundred sixty VT ablation procedures in 126 consecutive patients (114 men; age 65±12years) were performed. Endocardial CA succeeded in 250 (94%) out of 265 treated VT. For 15 (6%) VT an additional epicardial CA was performed and succeeded in 9 of these 15 VT. Long-term FU (25±18.2month) showed freedom of VT in 104 pts (82%) after 1.2±0.5 procedures, 11 (9%) suffered from repeated ICD shocks and 11 (9%) died due to worsening of heart failure.
CONCLUSIONS: Despite a heterogenic substrate for VT in SHD, endocardial CA alone results in high acute success rates. In this study additional epicardial CA following a sequential endocardial mapping and CA approach was performed in 6% of VT. Thus, due to possible complications epicardial CA should only be considered if endocardial CA fails.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epicardial ablation in structural heart disease

Mesh:

Year:  2014        PMID: 25576719     DOI: 10.1016/j.ijcard.2014.12.003

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  [Catheter ablation and the complications].

Authors:  D Steven; J H van den Bruck; T Plenge; J Lüker; A Sultan
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-12

2.  Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof-of-Concept from Experimental Studies to Clinical VF.

Authors:  David E Krummen; Justin Hayase; Stephen P Vampola; Gordon Ho; Amir A Schricker; Gautam G Lalani; Tina Baykaner; Taylor M Coe; Paul Clopton; Wouter-Jan Rappel; Jeffrey H Omens; Sanjiv M Narayan
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-06

Review 3.  [3-D mapping of ventricular tachycardia in patients with dilative cardiomyopathy].

Authors:  Daniel Steven; Jan-Hendrik van den Bruck; Jakob Lüker; Tobias Plenge; Arian Sultan
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-06

4.  The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia.

Authors:  Ruben Schleberger; Jana M Schwarzl; Julia Moser; Moritz Nies; Alexandra Höller; Paula Münkler; Leon Dinshaw; Christiane Jungen; Marc D Lemoine; Philippe Maury; Frederic Sacher; Claire A Martin; Tom Wong; Heidi L Estner; Pierre Jaïs; Stephan Willems; Christian Eickholt; Christian Meyer
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.